Clinical Trial: Early Nivolumab Addition to Regorafenib in Patients With Hepatocellular Carcinoma in Second-Line (The GOING Trial)

Sanduzzi-Zamparelli M, Matilla A, Lledo JL, Muñoz-Martínez S, Varela M, Iñarrairaegui M, Perelló C, Mínguez B, Llarch N, Márquez L, Guerrero A, Iserte G, Castaño-García A, Carrión L, Fortuny M, Rimola J, García-Criado Á, Domenech G, Torres F, Rios- Guillermo J, Boix L, Samper E, Kateb À, Bruix J, Reig M.

Aliment Pharmacol Ther. 2026 Feb 23. doi: 10.1111/apt.70578. Online ahead of print.

PMID: 41725391

The journal National Library of Medicine (National Center for Biotechnology Information) has highlighted the work of the Abdominal Surgical Pathology Group, with the participation of María Varela Calvo (varelacmaria@uniovi.es).

Check the publication at the following  link